| Abstrakt: |
An approach to the synthesis of new conjugates of 3,5-bis(arylidene)-4-piperidone pharmacophore with bisphosphonate moiety separated from the nitrogen atom of piperidone ring by four methylene units has been developed. This approach is based on the reaction of tetraethyl vinylidene-1,1-bisphosphonate with the Grignard reagent containing a dioxolane-protected piperidone ring (4-piperidone ethylene ketal), which is followed by the crotonic condensation of bisphosphonate obtained with aromatic aldehydes. In vitro evaluation of antitumor activity of prepared conjugates 3a,b toward human cancer cell lines Caov3, Scov3, KB3-1, KB8-5, A549, and MCF7 has revealed that these compounds possess moderate antitumor activity and are inferior in cytotoxicity to the analogs 1a,b with one methylene unit between piperidone and bisphosphonate moieties. [ABSTRACT FROM AUTHOR] |
Full text from SpringerLink